International Cannabis Weekly: 413
August 15, 2025
Highlights
Share this story
Highlights
CANNABIS STOCKS HIT HIGHEST POINT THIS YEAR ON TRUMP RESCHEDULING HOPES
Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from the US President on cannabis rescheduling. Â As Business of Cannabis reported earlier this week, on Monday, President Trump publicly addressed the long-stalled rescheduling project for the first time since taking office.
GERMAN HEALTH INSURERS HAVE MOVED TO STOP COVERING FLOWER COSTS
HIGH TIDE TO ACQUIRE A MAJORITY STAKE IN REMEXIAN PHARMA GMBH
Highlights
Share this story
Europe
- German cannabis firms chase record growth while UK operators plan market exits.
- Tilray Medical enters strategic partnership to expand patient access to medical cannabis in Europe.
- New research suggests medical cannabis could provide relief for people living with chronic pain.
- Artelo Biosciences secures extended European patent protection for cannabinoid-based therapies.
- Ondara directorate has planted Spain’s first medicinal cannabis crop in Garray facility.
- Fohse and Innexo partner to advance cannabis cultivation research and innovation.
Highlights
Share this story
NEW Data & Insights
Highlights
Share this story
United States
- Federally funded study shows cannabis use helps veterans reduce PTSD symptoms on use days.
- President Trump says decision on cannabis legalisation will be left to individual states.
- Oklahoma cannabis activists launch interactive map of hundreds of petition-signing locations for 2026 ballot.
- Cresco Labs has posted $164 million in new revenue for the second quarter of 2025.
- New York cannabis dispensaries located near schools have been permitted to remain open.
- Michigan has signed MOU with Bay Mills Indian Community for cannabis cooperation.
Highlights
Share this story
Canada
- Green Thumb Industries reports Q2 2025 results showing steady revenue performance.
- Village Farms sees strong Q2 2025 results on major rise in international cannabis sales.
- Organigram has posted record-breaking third quarter results for its fiscal year 2025.
- A look at the evolving medical and recreational cannabis landscape in Canada.
- Alberta’s cannabis regulator drops criminal record checks for industry workers.
- Canadian medical cannabis exports to Germany grow as government weighs tighter patient access rules.
- Cronos stock rallies amid broader cannabis sector surge over possible US rescheduling.
Highlights
Share this story
LATAM & The Caribbean
- Federal court to decide on unregistered cannabis-based medicine request at ANVISA.
- Panama’s ambassador to the UN has addressed the country’s stance on cannabis.
- Brazil has moved to position itself as a rising global leader in the medical cannabis industry.
- Indigenous community in Mexico gains legal approval to cultivate cannabis for the first time.
- Argentina’s health ministry redefines REPROCANN programme and tightens cultivation oversight.
- CBD vs THC in Brazil: What are the key differences, therapeutic applications, and legal statuses.
Highlights
Share this story
APAC
- Thailand considers easing cannabis regulations further to boost tourism sector.
- Aurora has expanded globally with Whistler Cannabis Co. brand launch in Australia.
- Sri Lanka opens legal cannabis cultivation opportunities to foreign investors.
- Australia has watched SAS-B approvals rise in July with pastilles surpassing 20% share.
Highlights
Share this story
Africa & The Middle East
- A study finds that Morocco’s local ‘beldiya’ cannabis variety shows superior stability.
- Morocco completes first-ever export of domestically grown medical cannabis to Australia
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.

